Search Results - "Langlet, P"

Analysis of the blurring in stencil lithography by Vazquez-Mena, O, Villanueva, L G, Savu, V, Sidler, K, Langlet, P, Brugger, J

“…A quantitative analysis of blurring and its dependence on the stencil-substrate gap and the deposition parameters in stencil lithography, a high resolution…”
Get more information

O077 : Use of direct oral anticoagulants (DOACs) in patients with splanchnic vein thrombosis and/or cirrhosis by De Gottardi, A, Seijo, S, Plessier, A, Schouten, J, Trebicka, J, Terziroli, B, Magenta, L, Semela, D, Langlet, P, Turon, F, Arya, R, Peck-Radosavljevic, M, Valla, D, Garcia-Pagan, J.C

Get full text

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study by VERSET, G, VERSLYPE, C, VAN LAETHEM, J-L, REYNAERT, H, BORBATH, I, LANGLET, P, VANDEBROEK, A, PEETERS, M, HOUBIERS, G, FRANCQUE, S, ARVANITAKIS, M

“…To assess the efficacy of the combination of long-acting release (LAR) octreotide and tamoxifen (TMX) for the treatment of advanced hepatocellular carcinoma…”
Get full text

Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis by Mesquita, M, Lasser, L, Langlet, P

“…Glomerulonephritis (GN) is an uncommon but well-described complication of chronic hepatitis B virus (HBV) infection. HBV-related membranous nephropathy (MN)…”
Get more information

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients by Langlet, P, D'Heygere, F, Henrion, J, Adler, M, Delwaide, J, Van Vlierberghe, H, Mulkay, J P, Lasser, L, Brenard, R, Horsmans, Y, Michielsen, P, Laureys, A, Nevens, F

“…The combination therapy of pegylated-interferon-alpha2a plus ribavirin is considered as the standard of care for patients with chronic hepatitis C. A sustained…”
Get full text

Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients by LANGLET, P., D’HEYGERE, F., HENRION, J., ADLER, M., DELWAIDE, J., VAN VLIERBERGHE, H., MULKAY, J. P., LASSER, L., BRENARD, R., HORSMANS, Y., MICHIELSEN, P., LAUREYS, A., NEVENS, F.

“…Summary Background  The combination therapy of pegylated‐interferon‐α2a plus ribavirin is considered as the standard of care for patients with chronic…”
Get full text

1010 ENTERAL NUTRITION WITH OR WITHOUT N-ACETYLCYSTEINE IN THE TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS: A RANDOMIZED, MULTICENTER, CONTROLLED TRIAL by Moreno, C, Langlet, P, Hittelet, A, Evrard, S, Lasser, L, Colle, I, Lemmers, A, Devière, J, Le Moine, O

Get full text

High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry by Francque, S, De Maeght, S, Adler, M, Deltenre, P, de Galocsy, C, Orlent, H, Van Steenbergen, W, Bastens, B, Wain, E, Langlet, P, Lasser, L, Verlinden, W, Van Marck, E, Henrion, J

“…Non-alcoholic Fatty Liver Disease (NAFLD) is increasingly recognised as a source of liver related morbidity and mortality. Hard data on epidemiology and…”
Get more information

711 HEPATITIS B VIRUS (HBV) INFECTION IN BELGIUM: RESULTS OF THE BELGIAN ASSOCIATION FOR THE STUDY OF THE LIVER (BASL) REGISTRY OF 1421 HBSAG CHRONIC CARRIERS by Deltenre, P, Laleman, W, van Gossum, M, Lenaerts, A, Colle, I, Adler, M, Michielsen, P, Assene, C, Delwaide, J, Orlent, H, Reynaert, H, D'Heygere, F, Langlet, P, Robaeys, G, de Galocsy, C, Brenard, R, Sprengers, D, Mairlot, M.-C, Preux, C, Lefèbvre, V, Henrion, J

Get full text

A pilot observational survey of hepatitis C in Belgium by De Maeght, S, Henrion, J, Bourgeois, N, de Galocsy, C, Langlet, P, Michielsen, P, Reynaert, H, Robaeys, G, Sprengers, D, Orlent, H, Adler, M

“…There is a lack of epidemiological data on hepatitis C (HCV) infected patients in Belgium. Therefore our purpose was to address this important question and to…”
Get more information

[3] A PROSPECTIVE FOLLOW-UP STUDY ON 163 PATIENTS WITH BUDD-CHIARI SYNDROME: RESULTS FROM THE EUROPEAN NETWORK FOR VASCULAR DISORDERS OF THE LIVER (EN-VIE) by Murad, S. Darwish, Plessier, A, Guerra, M. Hernandez, Primignani, M, Elias, E, Bahr, M, Hadengue, A, Langlet, P, Miranda, H, Pagan, J.C. Garcia, Valla, D.C, Janssen, H.L.A

Get full text

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas ( Observatoire dédié au Cancer Bretagne / Pays de la Loire ) by Metges, J P, Lebot, M A, Faroux, R, Riaud, F, Gamelin, E, Capitain, O, Guérin Meyer, V, Leynia, P, Douillard, J Y, Senellart, H, Rochard, S, Louvigné, C, Campion, L, Dupuis, O, Grollier, C, Achour, N A, Person, B, Raoul, J L, Boucher, E, Bertrand, C, Ramée, J F, Guivarch, L, Etienne, P L, Roussel, S, Desclos, H, Julien, M N, Labarre, M I, Klein, V, Bessard, R, Stampfli, C, Royet, F, Faycal, J, Gouva, S, Le Bihan, G, Couturier, M, Gourlaouen, A, Bertholom, C, Porneuf, M, Jobard, E, Peguet, E, Grasset, D, Bouret, J F, Bicheler, V, Ulvoas, A, Miglianico, L, Chouzenoux, C, Deguiral, P, Derenne, L, Martin, D, Langlet, P Michel, Bodin, C, Rossi, V, Barré, S, Cojocarasu, O, Naveau Ploux, C, Vidal, A M, Cumin, I, Egreteau, J, Brouard, A, Matysiak Budnik, T, Thomaré, P, Le Bris Michel, A S, Piriou, G, Largeau, R, Elhannani, C, Crespeau, E, Suberville, F, Bourgeois, H, Riche, C, Lagadec, D Déniel, Marhuenda, F, Grudé, F

“…In 2006, bevacizumab, a targeted therapy agent was combined with FOLFIRI for the firstline treatment of patients with unresectable metastatic colorectal…”
Get full text

Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines by Colle, I, Adler, M, Brenard, R, Henrion, J, Langlet, P, Michielsen, P, Orlent, H, Reynaert, H, Sprengers, D, Stärkel, P, Van Damme, P, Verslype, C, Delwaide, J

Get more information

Boceprevir for Untreated Chronic HCV Genotype 1 Infection by Poordad, Fred, McCone, Jonathan, Bacon, Bruce R, Bruno, Savino, Manns, Michael P, Sulkowski, Mark S, Jacobson, Ira M, Reddy, K. Rajender, Goodman, Zachary D, Boparai, Navdeep, DiNubile, Mark J, Sniukiene, Vilma, Brass, Clifford A, Albrecht, Janice K, Bronowicki, Jean-Pierre

“…In this trial involving previously untreated patients infected with hepatitis C virus (HCV) genotype 1, boceprevir in combination with peginterferon and…”
Get full text

Comment interpréter une élévation de la ferritine sérique ? by LANGLET, P, DELWAIDE, J

Get full text

Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose by MOREAU, R, CHAGNEAU, C, VALLA, D, LEBREC, D, HELLER, J, CHEVENNE, D, LANGLET, P, DELTENRE, P, HILLAIRE, S, LEFILLIATRE, P, PATERON, D, SOGNI, P

“…In patients with cirrhosis, glucose may induce splanchnic and renal vasodilation. Since the antidiabetic sulfonylurea glibenclamide is known to induce…”
Get full text

Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus by Ganem, G, Dubray, B, Raoul, Y, Colin, P, Bardet, E, Douillard, J Y, Goudier, M J, Hennequin, C, Walter, S, Michel-Langlet, P, Martin, P, Maron, D, Morvan, F, Andolenko, P, Extra, J M

“…To conduct a multicenter phase II study of a concomitant combination of chemotherapy and radiotherapy followed by surgery, where feasible, in patients with…”
Get more information

FINITE ELEMENT MODELLING OF RADIATING WAVES IN IMMERSED WEDGES by Hladky-Hennion, A.-C., Langlet, P., Bossut, R., de Billy, M.

“…The propagation of acoustic waves in immersed waveguides has been previously studied with the help of the finite element method, by using the ATILA code (A. C…”
Get full text

Miniature piezoelectric hollow sphere transducers (BBs) by Alkoy, S., Dogan, A., Hladky, A.-C., Langlet, P., Cochran, J.E., Newnham, N.E.

“…Miniature piezoelectric transducers were prepared from millimeter size hollow spheres which were formed from PZT-5A powder slurries using a coaxial nozzle…”
Get full text

Hemodynamic, Metabolic and Hormonal Responses to Oral Glibenclamide in Patients with Cirrhosis Receiving Glucose by R. Moreau, C. Chagneau, J. Heller, D. Chevenne, P. Langlet, P. Deltenre, S. Hillaire, P. Lefilliatre, D. Pateron, P. Sogni, D. Valla, D. Lebrec

“…Background: In patients with cirrhosis, glucose may induce splanchnic and renal vasodilation. Since the antidiabetic sulfonylurea glibenclamide is known to…”
Get full text